<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with refractory relapsed <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> underwent an autologous bone marrow transplant in July 1987 and achieved remission of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>He had complete hematological recovery but developed <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> 3 years post bone marrow transplantation with morphological evidence of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>High-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, 200 mg/kg, chemotherapy followed by an allogeneic bone marrow transplant from a HLA-matched sibling was performed in April 1991 with complete hematological recovery </plain></SENT>
<SENT sid="3" pm="."><plain>Allogeneic bone marrow transplantation was thus used successfully to treat a potential complication of autologous bone marrow transplantation </plain></SENT>
</text></document>